Przejdź do zawartości
Merck

Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage.

Annals of emergency medicine (2012-05-12)
Paul Gee, Cheryl Tallon, Neil Long, Grant Moore, Ronald Boet, Suzanne Jackson
ABSTRAKT

Dimethylamylamine (DMAA) was a forgotten pharmaceutical that was patented in 1944 as a nasal decongestant. DMAA has recently gained popularity as a dietary supplement, with claims of effectiveness as an athletic performance enhancer and weight loss aid. It is also sold as a recreational stimulant drug. DMAA is a sympathomimetic and potent pressor agent. This report describes 3 cases of cerebral hemorrhage in adults after the use of DMAA. The status of this substance as a synthetic or naturally occurring compound is also discussed.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
N,N-Dimethylethylamine, 99%
Sigma-Aldrich
N,N-Dimethylethylamine, ≥99%